| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.5 |
1 |
0.25 － 1 |
Minocycline (Minocycline hydrochloride, Minocin)  |
410 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.5 |
1 |
0.25 － 2 |
Cefuroxime (Kefurox, Zinacef) |
1492 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.5 |
1 |
0.5 － 1 |
SCH27899 |
129 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.5 |
1 |
0.5 － 32 |
Cefprozil (Cefzil) |
1492 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.5 |
2 |
0.03 － 2 |
Zosyn |
102 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.5 |
2 |
0.125 － 2 |
Cefditoren (Spectracef) |
56 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.5 |
4 |
0.03 － 16 |
Cefepime (Maxipime) |
113 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.5 |
8 |
0.25 － 16 |
Cefpodoxime |
600 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
1 |
0.5 － 1 |
Linezolid (PNU-100766, U-100766, Zyvox) |
115 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
1 |
0.5 － 1 |
Vancomycin (Vancocyn, Lyphocin) |
115 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
1 |
0.5 － 2 |
Eperezolid (PNU-100592) |
33 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
1 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
7 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
1 |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
1060 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
2 |
0.06 － 16 |
Cefoperazone (Cefobid) |
113 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
2 |
0.25 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
11 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
2 |
0.5 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
186 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
2 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
186 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
2 |
0.5 － 4 |
Cefpodoxime |
1492 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
2 |
1 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
11 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
2 |
1 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
248 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
2 |
1 － 8 |
Cefaclor (Ceclor, Ceclor CD) |
1492 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
2 |
1 － 16 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1060 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
4 |
0.125 － 4 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
248 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
4 |
0.25 － 4 |
Cefazolin (Ancef, Kefzol, Zolicef) |
248 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
8 |
0.015 － 16 |
Cefotaxime (Cephotaxime, Claforan) |
113 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
8 |
0.25 － 8 |
Amikacin (Amikin) |
248 |
| Staphylococcus epidermidis (methicillin-susceptible) |
1 |
16 |
0.03 － 64 |
Ceftriaxone (Rocephin) |
113 |
| Staphylococcus epidermidis (methicillin-susceptible) |
2 |
2 |
2 － ? |
GSQ1530 |
1060 |